The effect of oral supplementation of Paricalcitol on C-reactive protein levels in chronic kidney disease patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials
View abstract on PubMed
Summary
This summary is machine-generated.Oral paricalcitol supplementation significantly reduces C-reactive protein levels in chronic kidney disease (CKD) patients. This finding suggests a potential therapeutic benefit for managing CKD progression.
Area Of Science
- Nephrology
- Pharmacology
Background
- Investigates the impact of oral paricalcitol on C-reactive protein (CRP) levels in chronic kidney disease (CKD).
- Addresses inconsistent findings from previous studies on paricalcitol's effect on CRP in CKD patients.
Approach
- Systematic review and meta-analysis of randomized clinical trials.
- Searched MEDLINE, Scopus, and Web of Science databases up to January 2023.
- Utilized a random effect model to calculate weighted mean differences (WMD) and 95% confidence intervals (CI).
Key Points
- Included 4 studies (6 arms) from an initial 182 articles.
- Pooled analysis revealed a significant decrease in CRP levels post-paricalcitol supplementation (WMD: -2.55 mg/L).
- Observed significant heterogeneity among the included studies (I² = 66.3%, P = 0.01).
Conclusions
- Oral paricalcitol supplementation effectively reduces CRP levels in CKD patients.
- This reduction in CRP may play a role in preventing the progression of chronic kidney disease.
Related Concept Videos
Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

